Session Information
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer in Singapore
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
All times listed are in Singapore time (GMT+8)
PL - Plenary
PS - Presidential Symposium
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
IS - Industry Symposium
JICC - Joint IASLC-CAALC-CSCO Session
January 28 Thu
Jan 28 Friday
January 29 Fri
Jan 29 Saturday
January 30 Sat
Jan 30 Sunday
January 31 Sun
Jan 31
-
+
P39 - Patient Advocacy
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Patient Advocacy
-
+
P39.01 - Satisfaction with the Lung Cancer Care Pathway. Is it time to Revise the way we Monitor and Assess Patient Experience?
00:00 - 00:00 | Presenter: Yvonne Nartey
- Abstract
Loading... -
+
P39.02 - ‘Making Moments Matter’ – A Lung Cancer Campaign from the Marie Keating Foundation
00:00 - 00:00 | Presenter: Anne Marie Baird
- Abstract
Loading... -
+
P39.03 - Developing A Collaborative Northern Roadmap for Lung Cancer Care
00:00 - 00:00 | Presenter: Carolyn Roberts
- Abstract
Loading... -
+
P39.04 - ALK Positive UK: 42% of UK Patients do not Receive Regular Brain MRI Scans Despite Data Showing up to 70% of Patients Develop Brain Metastases
00:00 - 00:00 | Presenter: Debra Montague
- Abstract
Loading... -
+
P39.05 - Access Disparities and Challenges in Lung Cancer Diagnostics and Treatment – A European Perspective
00:00 - 00:00 | Presenter: Anne Marie Baird
- Abstract
Loading... -
+
P39.06 - Surviving Metastatic Non-Small Cell Lung Cancer – Experience and Supportive Care Needs of Patients Receiving Novel Therapies
00:00 - 00:00 | Presenter: Sarah Ellen Heynemann
- Abstract
Loading... -
+
P39.07 - Evaluating the Success of the First Global Lung Cancer Coalition Patient Experience Survey
00:00 - 00:00 | Presenter: Vanessa Beattie
- Abstract
Loading... -
+
P39.08 - The Effect of COVID-19 on Anxiety in Canadian Lung Cancer Patients
00:00 - 00:00 | Presenter: Christina Sit
- Abstract
Loading... -
+
P39.09 - Social Media Support of Lung Cancer Patient Associations During the Lockdown Restrictions in Italy: A Breath of Life During the COVID-19 Pandemic.
00:00 - 00:00 | Presenter: Tindara Franchina
- Abstract
Loading...
-
+
P40 - Risk Reduction and Tobacco Control
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Risk Reduction and Tobacco Control
-
+
P40.01 - Tobacco use in Adolescence and Associated Factors: Products, School, Family, Peers and Movies in Pandemic Period
00:00 - 00:00 | Presenter: Domenico Galetta
- Abstract
Loading... -
+
P40.02 - Female Lung Cancer: An Emerging Issue in Bangladesh
00:00 - 00:00 | Presenter: Nausheen Hakim
- Abstract
Loading... -
+
P40.03 - Report on a Phytochemical-rich Dietary Intervention Trial to Prevent Lung Cancer: Implementation in a High-Risk Lung Screening Clinic
00:00 - 00:00 | Presenter: Marisa Bittoni
- Abstract
Loading... -
+
P40.04 - Knowledge, Attitudes and Perception of Lung Cancer Screening Among Smoking Soft-Ware Professionals in India
00:00 - 00:00 | Presenter: Venkata pradeep babu Koyyala
- Abstract
Loading... -
+
P40.05 - Current Status of a Smoking Cessation Supportive Program on Nurses' Interventions: A Single Institutional Experience
00:00 - 00:00 | Presenter: Reiko Kori
- Abstract
Loading...
-
+
P41 - Screening and Early Detection - Lung Cancer Screening Programmes
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Screening and Early Detection
-
+
P41.01 - Disparities in Lung Cancer Screening by Baseline Comorbidities: An Analysis of the Behavioral Risk Factor Surveillance System Survey 2018
00:00 - 00:00 | Presenter: Qian Wang
- Abstract
Loading... -
+
P41.02 - Implementation Barriers In US-based Lung Cancer Screening Programs
00:00 - 00:00 | Presenter: Andrew Ciupek
- Abstract
Loading... -
+
P41.03 - Long-Term Results of Screening-Detected Lung Cancer in the Polish Cohort.
00:00 - 00:00 | Presenter: Robert Dziedzic
- Abstract
Loading... -
+
P41.04 - The SUMMIT Study: Pulmonary Nodule and Incidental Findings in the First 10,000 Participants of a Population-Based Low-Dose CT Screening Study
00:00 - 00:00 | Presenter: Jennifer L Dickson
- Abstract
Loading... -
+
P41.05 - Challenges of Implementing Lung Cancer Screening in Brazil: Preliminary Results of a Multicenter Group
00:00 - 00:00 | Presenter: Ricardo Santos
- Abstract
Loading... -
+
P41.06 - As Seen from the Rearview Mirror: A Retrospective Analysis of Lung Cancer Screening in Patients with Lung Cancer
00:00 - 00:00 | Presenter: Coral Olazagasti
- Abstract
Loading... -
+
P41.07 - Lung Cancer Screening: What is the State of the Evidence about Implementation?
00:00 - 00:00 | Presenter: Nicole Rankin
- Abstract
Loading... -
+
P41.09 - Comorbidity Profile and Diagnostic Complication Risk: A Study of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
00:00 - 00:00 | Presenter: Eric M Robinson
- Abstract
Loading... -
+
P41.10 - Initial Low Dose CT for Lung Cancer Screening and Recalls at Kaiser Permanente Mid-Atlantic States
00:00 - 00:00 | Presenter: Monica Ter-Minassian
- Abstract
Loading...
-
+
P42 - Screening and Early Detection - Risk Modelling and Artificial Intelligence
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Screening and Early Detection
-
+
P42.01 - AI Assistance for Pulmonary Nodule Stratification: An Multiple-Reader Multiple-Case Study
00:00 - 00:00 | Presenter: Emma O'Dowd
- Abstract
Loading... -
+
P42.02 - Evaluating the Feasibility of a Deep Learning-Based Computer-Aided Detection System for Lung Nodule Detection in a Lung Cancer Screening Program
00:00 - 00:00 | Presenter: Sunyi Zheng
- Abstract
Loading... -
+
P42.03 - A Dynamic Deep Learning Approach to Predict Clinical Outcomes of Patients with Advanced Non-Small Cell Lung Cancer under Nivolumab Monotherapy
00:00 - 00:00 | Presenter: Shun Lu
- Abstract
Loading... -
+
P42.04 - Is AI Better for Prediction of Pathologial Subtype in Pulmonary Nodules?
00:00 - 00:00 | Presenter: shuaibo Wang
- Abstract
Loading... -
+
P42.05 - Investigating the Accuracy of Clinical Mathematical Models for Estimating the Probability of Malignancy in Patients With Pulmonary Nodules
00:00 - 00:00 | Presenter: Kevin Zhang
- Abstract
Loading... -
+
P42.06 - Automatic Lung Nodule Detection by a Deep Learning-Based CAD System: The Value of Slab Thickness in the Maximum Intensity Projection Technique
00:00 - 00:00 | Presenter: Sunyi Zheng
- Abstract
Loading... -
+
P42.07 - Comparative Performance of Lung Cancer Risk Models to Define Lung Screening Eligibility in the United Kingdom
00:00 - 00:00 | Presenter: Hilary A Robbins
- Abstract
Loading... -
+
P42.08 - Association Between the Age at First-Live Birth and Lung Cancer Risk: Meta-Analysis and Mendelian Randomization Analysis
00:00 - 00:00 | Presenter: Yiyuan Ao
- Abstract
Loading...
-
+
P43 - Screening and Early Detection - Biomarkers
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Screening and Early Detection
-
+
P43.01 - Utility of Sputum for Non-Invasive Assessment of Lung Cancer Risk with the LuCED® Test: Specimen Satisfactory Rate
00:00 - 00:00 | Presenter: Michael Meyer
- Abstract
Loading... -
+
P43.02 - A Multiplex Plasma Protein Panel for Detection of Lung Cancer in Ever Smokers Not Currently Eligible for Screening
00:00 - 00:00 | Presenter: Stephen Lam
- Abstract
Loading... -
+
P43.03 - Sphingomyelin Is a Candidate Predictor for Lung Adenocarcinoma Recurrence After Radical Surgery
00:00 - 00:00 | Presenter: Yusuke Takanashi
- Abstract
Loading... -
+
P43.04 - Efficient Isolation and Quantification of CTC in NSCLC Patients using Peptide-Functionalized Magnetic Nanoparticles
00:00 - 00:00 | Presenter: Naixin Liang
- Abstract
Loading...
-
+
P44 - Screening and Early Detection - Association of Lung Cancer with other Chronic Diseases
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Screening and Early Detection
-
+
P44.02 - Mild Interstitial Pneumonia as a Risk Factor for Chemotherapy-Induced Acute Exacerbation of Interstitial Pneumonia in Patients with Lung Cancer
00:00 - 00:00 | Presenter: Takashi Umeda
- Abstract
Loading... -
+
P44.03 - Combined Aortic Valve and Coronary Artery Calcifications in Lung Cancer Screening as Predictors of Death from Cardiovascular Disease
00:00 - 00:00 | Presenter: Yeqing Zhu
- Abstract
Loading... -
+
P44.04 - Evaluating Lung Cancer Screening in People Living With HIV
00:00 - 00:00 | Presenter: Shawn Jindal
- Abstract
Loading... -
+
P44.05 - Bone Density Measures Out-Perform Clinical Risk Scores in Detection of Vertebral Fractures in a Lung Cancer Screening Cohort
00:00 - 00:00 | Presenter: Nikita Patel
- Abstract
Loading...
-
+
P45 - Screening and Early Detection - Radiological Risk Stratification
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Screening and Early Detection
-
+
P45.01 - Lung Cancer Probability and Clinical Outcomes of Baseline and New Ground-Glass Opacity Nodules Detected on Low-Dose CT Screening
00:00 - 00:00 | Presenter: Yeon Wook Kim
- Abstract
Loading... -
+
P45.02 - Regional Emphysema Score Is Associated With Tumor Location and Poor Prognosis in Completely Resected NSCLC Patients
00:00 - 00:00 | Presenter: Chang Dong Yeo
- Abstract
Loading... -
+
P45.03 - Lung Nodule Management Based on Diameter and Volume in Lung Cancer Screening with Low-Dose Computed Tomography
00:00 - 00:00 | Presenter: Yihui Du
- Abstract
Loading... -
+
P45.04 - Radiologic and Clinical Features of Screening-Detected Pulmonary Invasive Mucinous Adenocarcinoma
00:00 - 00:00 | Presenter: Dae Hyeon Kim
- Abstract
Loading...
-
+
P46 - Screening and Early Detection - Gene-Based Risk Stratification
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Screening and Early Detection
-
+
P46.01 - Intronic Noncoding RNA Expression of DCN is Related to Cancer-Associated Fibroblasts and NSCLC Patients’ Prognosis
00:00 - 00:00 | Presenter: Jian Zhou
- Abstract
Loading... -
+
P46.02 - Correlation of Monitoring ctDNA EGFRm using R-SuperARMS with Clinical Outcomes in Patients with Advanced Lung Adenocarcinoma
00:00 - 00:00 | Presenter: Jiuwei Cui
- Abstract
Loading... -
+
P46.03 - DNA Methylation Analysis in Smokers and Non-Smokers (Passive and ex-Smokers)
00:00 - 00:00 | Presenter: Diana Monserrat Aguilar-Beltrán
- Abstract
Loading... -
+
P46.04 - Identify Lung Adenocarcinoma among Pulmonary Micro-nodules through Blood Gene Expression Profiles
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading... -
+
P46.05 - A Blood Six-Gene Test for Early-Stage Lung Adenocarcinoma Screening in Asympomatic Population
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading... -
+
P46.06 - Cell-Free DNA (cfDNA) Methylation Assay Allows for Early Detection and Identification of Lung Cancer
00:00 - 00:00
- Abstract
Loading... -
+
P46.07 - An Extended Targeted RNA Sequencing for Fusion Detection with Oncomine Comprehensive Assay Plus
00:00 - 00:00 | Presenter: Alex View Hune Teoh
- Abstract
Loading...
-
+
P47 - Small Cell Lung Cancer/NET - Biology / Translational
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Small Cell Lung Cancer/NET
-
+
P47.01 - Plasma Exosomal Long RNA in SCLC Diagnosis and Prognosis
00:00 - 00:00 | Presenter: Chang Liu
- Abstract
Loading... -
+
P47.02 - CCL19 Associates with Inferior Prognosis in Patients with SCLC Through Promoting Invasion and Metastasis
00:00 - 00:00 | Presenter: qian Liu
- Abstract
Loading... -
+
P47.03 - Understanding Lung Neuroendocrine Tumor Progression Combining Organoid Models and Multi-Omic Analyses
00:00 - 00:00 | Presenter: Nicolas Alcala
- Abstract
Loading... -
+
P47.04 - Neuroendocrine Transformation from EGFR-wild type or TKI-naïve Non-Small Cell Lung Cancer: An Under-Recognized Phenomenon?
00:00 - 00:00 | Presenter: Xiao Chu
- Abstract
Loading... -
+
P47.06 - Delta-Radiomics Features for Assessment of Individualized Therapeutic Response in Small Cell Lung Cancer – A Pilot Study
00:00 - 00:00 | Presenter: jose Arimateia Batista Araujo Filho
- Abstract
Loading... -
+
P47.07 - Exploration of Aberrant Methylation Patterns in the Chemotherapy Insensitivity of Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Peixin Chen
- Abstract
Loading... -
+
P47.08 - Blood-Based Tumor Mutation Burden as a Predictive Biomarker for Clinical Benefit of Immunotherapy in Small-Cell Lung Cancer
00:00 - 00:00 | Presenter: Xingsheng Hu
- Abstract
Loading... -
+
P47.09 - Quantification and Classification of Tumor Infiltrating Leukocytes (TILs) and its Impact on Prognosis in Small Cell Lung Cancer (SCLC)
00:00 - 00:00 | Presenter: Yiying Guo
- Abstract
Loading... -
+
P47.10 - Predicting ROR1/BCL2 Combination Targeted Therapy of Small Cell Carcinoma of the Lung
00:00 - 00:00 | Presenter: Walter Wang
- Abstract
Loading... -
+
P47.11 - DLL-3 and ASCL-1 Expression Emerge as Promising Therapeutic Targets in High-Grade Neuroendocrine Lung Tumors: A Preliminary Study
00:00 - 00:00 | Presenter: Tabatha Gutierrez Prieto
- Abstract
Loading... -
+
P47.12 - Does Pulmonary Adenocarcinoma With Neuroendocrine Differentiation Deserve A New Classification?
00:00 - 00:00 | Presenter: JIAXI He
- Abstract
Loading... -
+
P47.13 - Galectin-9, A Novel Prognostic Factor in Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Peixin Chen
- Abstract
Loading... -
+
P47.14 - Clinicopathologic Features of Large Cell Neuroendocrine Carcinoma of Lung
00:00 - 00:00 | Presenter: Perran Fulden Yumuk
- Abstract
Loading... -
+
P47.15 - Mutational Landscape of Homologous Recombination Pathway in Small Cell Lung Cancer Patients
00:00 - 00:00 | Presenter: Xin Li
- Abstract
Loading...
-
+
P48 - Small Cell Lung Cancer/NET - Chemo - IO
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Small Cell Lung Cancer/NET
-
+
P48.01 - Gemcitabine and Nivolumab for Subsequent Treatment of Metastatic Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Thomas William Lycan
- Abstract
Loading... -
+
P48.02 - NRG Oncology/Alliance LU005: Chemoradiation vs. Chemoradiation Plus Atezolizumab in Limited Stage Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Kristin A. Higgins
- Abstract
Loading... -
+
P48.03 - First-Line Durvalumab plus Platinum-Etoposide in ES-SCLC: Exploratory Analyses Based on Extent of Disease in CASPIAN
00:00 - 00:00 | Presenter: Niels Reinmuth
- Abstract
Loading... -
+
P48.04 - IMfirst; Phase IIIB Safety Study of Atezolizumab Plus Chemotherapy in a Real World Population of Untreated ES-SCLC
00:00 - 00:00 | Presenter: Rosario Garcia Campelo
- Abstract
Loading... -
+
P48.05 - Anlotinib Plus Platinum-Etoposide in 1st-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Single-Arm Phase II Trial
00:00 - 00:00 | Presenter: Peng-Bo Deng
- Abstract
Loading... -
+
P48.06 - Lurbinectedin in Combination with Pembrolizumab for Patients with Relapsed Small Cell Lung Cancer. LUPER Clinical Trial
00:00 - 00:00 | Presenter: Maria José De Miguel Luken, Bernard Gaston Doger Speville Uribe, Alejandro Navarro, Roldán Cortés, Antonio Calles
- Abstract
Loading... -
+
P48.07 - Synergistic Antitumor Effects of Anlotinib Combination With Oral 5-Fluorouracil S-1 in Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Haihua Yang
- Abstract
Loading... -
+
P48.09 - Anlotinib Plus Etoposide and Carboplatin as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: A Single Arm Phase II Trial
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading... -
+
P48.10 - Chemo-Immunotherapy in the Frontline of Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Indirect Comparisons
00:00 - 00:00 | Presenter: Antonio Galvano
- Abstract
Loading... -
+
P48.11 - Anlotinib Versus Chemotherapy as a Third-Line or Further Treatment for Advanced Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Yue Wang
- Abstract
Loading... -
+
P48.12 - A Meta-Analysis of ICI +EP vs. EP for Untreated Extensive SCLC using GRADE System Approach for Certainty in the Evidence.
00:00 - 00:00 | Presenter: Carolina Gabay
- Abstract
Loading... -
+
P48.13 - Immune Checkpoint Inhibitors Combined with Etoposide-Platinum as First-Line Therapy for Extensive-Stage SCLC: A Network Meta-Analysis
00:00 - 00:00 | Presenter: Jiuwei Cui
- Abstract
Loading... -
+
P48.14 - RESILIENT Part 2: A phase 3 Study of Liposomal Irinotecan in Patients with Small-Cell Lung Cancer in the Second-Line Setting
00:00 - 00:00 | Presenter: Luis Paz-Ares
- Abstract
Loading... -
+
P48.15 - A Case from a Single-Arm, Phase Two, Open Label Study Assessing Sindilimab Plus Metaformin in Chemotherapy Failed PD-L1 Positive Advanced SCLC
00:00 - 00:00
- Abstract
Loading... -
+
P48.16 - Network Meta-Analysis of ICI for Extensive Small-Cell Lung Cancer (ESCLC) as Upfront Therapy
00:00 - 00:00 | Presenter: Carolina Gabay
- Abstract
Loading... -
+
P48.17 - Efficacy and Safety of AK104, an Anti‐PD‐1/CTLA‐4 Bispecific Antibody, in a Patient with Large Cell Neuroendocrine Carcinoma of the Lung
00:00 - 00:00 | Presenter: Sophia Frentzas
- Abstract
Loading... -
+
P48.18 - Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis
00:00 - 00:00 | Presenter: Arani Sathiyapalan
- Abstract
Loading... -
+
P48.19 - Outcomes of Patients Treated with First Line Immunotherapy Plus Chemotherapy for ES-SCLC: Real World Outcomes from a Tertiary Academic Center
00:00 - 00:00 | Presenter: Sandip H Patel
- Abstract
Loading... -
+
P48.20 - Trends in Trial Design, Interpretation and Survival in Phase III Clinical Trials on Extensive-Stage SCLC Between 2000 and 2019
00:00 - 00:00 | Presenter: Chia Ching Lee
- Abstract
Loading... -
+
P48.21 - Population Pharmacokinetics and Exposure-Response with Durvalumab Plus Platinum-Etoposide in ES-SCLC: Results from CASPIAN
00:00 - 00:00 | Presenter: Yanan Zheng
- Abstract
Loading... -
+
P48.22 - Semi-Mechanistic Models of the Time Course of Neutrophils and Platelets in Cancer Patients Treated With Lurbinectedin
00:00 - 00:00 | Presenter: Salvador Fudio
- Abstract
Loading... -
+
P48.23 - Exposure-Response Analyses and Clinical Utility Index to Justify the Dosage of Lurbinectedin in Small-cell Lung Cancer
00:00 - 00:00 | Presenter: Salvador Fudio
- Abstract
Loading... -
+
P48.24 - Anlotinib Combined with Etoposide as Maintenance Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
00:00 - 00:00 | Presenter: Bo Shen
- Abstract
Loading...